Vaccinex, Inc. (VCNX)

Vaccinex Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	0.12	0.57	0.28	0.9	0.63	0.52
Revenue Growth (YoY)	-84.97%	107.27%	-69.44%	44.00%	19.50%	-27.76%
Cost of Revenue	0	0	0	0	0	0.2
Gross Profit	0.12	0.57	0.28	0.9	0.62	0.32
Selling, General & Admin	6.95	6.88	6.2	6.23	7.41	6.67
Research & Development	16.15	16.57	13.98	17.16	21.55	25.67
Operating Expenses	23.1	23.46	20.18	23.39	28.95	32.34
Operating Income	-22.97	-22.89	-19.91	-22.49	-28.33	-32.02
Interest Expense / Income	0	0	0	0.81	0.49	0
Other Expense / Income	-3.79	-2.64	-0.09	-0.92	0.03	-0.15
Pretax Income	-19.19	-20.25	-19.82	-22.38	-28.85	-31.86
Net Income	-19.19	-20.25	-19.82	-22.38	-28.85	-31.86
Shares Outstanding (Basic)	1	0	0	0	0	0
Shares Outstanding (Diluted)	1	0	0	0	0	0
Shares Change	458.78%	129.44%	47.10%	53.56%	45.85%	146.59%
EPS (Basic)	-27.16	-43.68	-98.05	-163.80	-323.40	-518.70
EPS (Diluted)	-27.16	-43.68	-98.05	-163.80	-323.40	-518.70
Free Cash Flow	-16.84	-17.3	-19.17	-25.33	-28.94	-30.79
Free Cash Flow Per Share	-12.69	-37.31	-94.88	-184.38	-323.46	-502.03
Gross Margin	100.00%	100.00%	100.00%	100.00%	99.68%	61.95%
Operating Margin	-18526.61%	-4014.91%	-7238.55%	-2498.89%	-4532.96%	-6121.41%
Profit Margin	-15472.58%	-3552.81%	-7205.45%	-2486.67%	-4616.16%	-6092.35%
Free Cash Flow Margin	-13583.87%	-3035.26%	-6972.00%	-2814.44%	-4629.92%	-5887.76%
EBITDA	-19.07	-20.13	-19.61	-21.4	-28.06	-31.61
EBITDA Margin	-15379.84%	-3531.75%	-7129.45%	-2378.00%	-4488.80%	-6044.74%
Depreciation & Amortization	0.12	0.12	0.21	0.17	0.31	0.25
EBIT	-19.19	-20.25	-19.81	-21.57	-28.36	-31.86
EBIT Margin	-15472.58%	-3552.63%	-7204.73%	-2396.78%	-4537.92%	-6092.35%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).